Viatris – Global Leader in Quality Pharmaceutical Solutions

Viatris

Country: United States

Viatris Inc. is a US pharmaceutical company headquartered in Canonsburg, Pennsylvania. It was formed in November 2020 by combining the generics maker Mylan with Upjohn, a former Pfizer division that held well-known off-patent branded medicines. Viatris shares trade on Nasdaq and the company is part of the S&P 500 index.

Viatris's portfolio combines Mylan's generics with Upjohn brands such as Lipitor (atorvastatin), Viagra (sildenafil) and Xanax (alprazolam). The company works in cardiovascular medicine, infectious diseases, oncology, immunology, neurology and psychiatry, diabetes and metabolism, gastroenterology, respiratory medicine and dermatology.

After the merger the company narrowed its focus: in 2022 it transferred its biosimilars business to India's Biocon Biologics, and in 2023 it agreed to sell most of its over-the-counter business, its women's healthcare business and its active-ingredient manufacturing in India.

Revatio (sildenafil), a medicine for pulmonary arterial hypertension, came to Viatris with the Upjohn portfolio.

Unifarm carries Viatris's Revatio 20 (sildenafil), used to treat pulmonary arterial hypertension.

Official manufacturer website
Viatris

List of medicines by manufacturer Viatris

-3%
Revatio 20
View
Viatris
20 mg 90 tablets
7465₴ 7733₴
✅ All products loaded (1)

Contact us

Choose a convenient way to contact

We work daily from 9:00 to 20:00